158.256 de modificări
Global Blood Therapeutics Inc: Diferență între versiuni
Global Blood Therapeutics Inc (modificare)
Versiunea de la data 18 septembrie 2024 19:58
, 18 septembriePagină nouă: Pagina dedicata companiei Global Blood Therapeutics Inc listata cu simbolul US.GBT ==Descriere companie== Global Blood Therapeutics, Inc.(www.gbt.com) is a biopharmaceutical company that discovers, develops and delivers treatments. The company has introduced Oxbryta (voxelotor) tablets, the Food and Drug Administration (FDA) approved treatment that directly inhibits sickle hemoglobin polymerization, the root cause of red blood cell sickling in sickle cell disease (SCD). The...
Admin (discuție | contribuții) (Pagină nouă: Pagina dedicata companiei Global Blood Therapeutics Inc listata cu simbolul US.GBT ==Descriere companie== Global Blood Therapeutics, Inc.(www.gbt.com) is a biopharmaceutical company that discovers, develops and delivers treatments. The company has introduced Oxbryta (voxelotor) tablets, the Food and Drug Administration (FDA) approved treatment that directly inhibits sickle hemoglobin polymerization, the root cause of red blood cell sickling in sickle cell disease (SCD). The...) |
(Nicio diferență)
|